Versant Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $998K | Sell |
9,645
-1,314
| -12% | -$117K | 0.09% | 129 |
|
|
2026
Q1 | $787K | Buy |
10,959
+3,273
| +43% | +$252K | 0.08% | 157 |
|
|
2025
Q4 | $610K | Sell |
7,686
-248
| -3% | -$19.6K | 0.08% | 172 |
|
|
2025
Q3 | $598K | Sell |
7,934
-1,614
| -17% | -$111K | 0.08% | 162 |
|
|
2025
Q2 | $659K | Buy |
9,548
+5,487
| +135% | +$360K | 0.1% | 122 |
|
|
2025
Q1 | $275K | Buy |
4,061
+3,067
| +309% | +$184K | 0.05% | 314 |
|
|
2024
Q4 | $44.6K | Buy |
994
+115
| +13% | +$6.45K | 0.01% | 630 |
|
|
2024
Q3 | $55.3K | Buy |
879
+642
| +271% | +$37.5K | 0.01% | 412 |
|
|
2024
Q2 | $14K | Sell |
237
-110
| -32% | -$6.88K | ﹤0.01% | 846 |
|
|
2024
Q1 | $27.7K | Buy |
347
+109
| +46% | +$8.33K | 0.01% | 400 |
|
|
2023
Q4 | $18.8K | Sell |
238
-421
| -64% | -$30K | 0.01% | 519 |
|
|
2023
Q3 | $46K | Sell |
659
-2
| -0.3% | -$142 | 0.01% | 275 |
|
|
2023
Q2 | $45.7K | Buy |
661
+37
| +6% | +$2.63K | 0.01% | 290 |
|
|
2023
Q1 | $46.4K | Buy |
624
+400
| +179% | +$33.5K | 0.02% | 274 |
|
|
2022
Q4 | $20.9K | Hold |
224
| – | – | 0.01% | 436 |
|
|
2022
Q3 | $21K | Hold |
224
| – | – | 0.01% | 408 |
|
|
2022
Q2 | $21K | Sell |
224
-18
| -7% | -$1.76K | 0.01% | 415 |
|
|
2022
Q1 | $24K | Buy |
242
+12
| +5% | +$1.26K | 0.01% | 421 |
|
|
2021
Q4 | $24K | Hold |
230
| – | – | 0.01% | 437 |
|
|
2021
Q3 | $20K | Sell |
230
-24
| -9% | -$2.01K | 0.01% | 472 |
|
|
2021
Q2 | $21K | Sell |
254
-159
| -38% | -$13K | 0.01% | 460 |
|
|
2021
Q1 | $31K | Hold |
413
| – | – | 0.01% | 419 |
|
|
2020
Q4 | $28K | Sell |
413
-2
| -0.5% | -$130 | 0.01% | 397 |
|
|
2020
Q3 | $24K | Sell |
415
-8
| -2% | -$498 | 0.01% | 372 |
|
|
2020
Q2 | $27K | Buy |
423
+16
| +4% | +$1.01K | 0.01% | 338 |
|
|
2020
Q1 | $24K | Sell |
407
-11
| -3% | -$734 | 0.01% | 316 |
|
|
2019
Q4 | $31K | Sell |
418
-3
| -0.7% | -$211 | 0.02% | 329 |
|
|
2019
Q3 | $26K | Buy |
421
+4
| +1% | +$237 | 0.01% | 369 |
|
|
2019
Q2 | $22K | Sell |
417
-480
| -54% | -$25.8K | 0.01% | 437 |
|
|
2019
Q1 | $48K | Sell |
897
-537
| -37% | -$33.1K | 0.02% | 282 |
|
|
2018
Q4 | $93K | Buy |
1,434
+133
| +10% | +$9.93K | 0.04% | 141 |
|
|
2018
Q3 | $102K | Sell |
1,301
-5
| -0.4% | -$357 | 0.04% | 147 |
|
|
2018
Q2 | $84K | Sell |
1,306
-23
| -2% | -$1.52K | 0.04% | 178 |
|
|
2018
Q1 | $82K | Sell |
1,329
-44
| -3% | -$3.16K | 0.03% | 178 |
|
|
2017
Q4 | $99K | Sell |
1,373
-250
| -15% | -$18.2K | 0.04% | 168 |
|
|
2017
Q3 | $131K | Buy |
1,623
+14
| +0.9% | +$1.11K | 0.07% | 101 |
|
|
2017
Q2 | $129K | Sell |
1,609
-31
| -2% | -$2.45K | 0.07% | 102 |
|
|
2017
Q1 | $128K | Buy |
1,640
+141
| +9% | +$11.3K | 0.07% | 105 |
|
|
2016
Q4 | $118K | Buy |
1,499
+32
| +2% | +$2.59K | 0.07% | 113 |
|
|
2016
Q3 | $130K | Sell |
1,467
-47
| -3% | -$4.44K | 0.07% | 104 |
|
|
2016
Q2 | $144K | Sell |
1,514
-56
| -4% | -$5.58K | 0.09% | 91 |
|
|
2016
Q1 | $162K | Sell |
1,570
-45
| -3% | -$4.38K | 0.1% | 83 |
|
|
2015
Q4 | $157K | Buy |
+1,615
| New | +$158K | 0.1% | 84 |
|
Other funds holding CVS
LMFP
CF
HCM
FWIA
CGH
Versant Capital Management's CVS Position: Q2 2026 in Review
Versant Capital Management reduced its CVS Health (CVS) stake by 12% in Q2 2026, selling an estimated $117K and leaving 9,645 shares worth $998K. The position accounts for 0.09% of the portfolio, ranked #129.
Versant Capital Management first reported a position in CVS in Q4 2015 and has held it in 43 quarters since. 505 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Versant Capital Management held 9,645 shares of CVS Health worth $998K as of Q2 2026.
- Versant Capital Management sold 1,314 CVS Health shares in Q2 2026, an estimated $117K.
- CVS Health made up 0.09% of Versant Capital Management's portfolio in Q2 2026, its #129 holding.
- Versant Capital Management first reported a position in CVS Health in Q4 2015 and has held it in 43 quarters since.
- 505 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.